Concepedia

Amanda Abbott

AA

7

Publications

472

Citations

7

H-Index

1956

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Pfizer (United States)

Harvard University

Yale University

Amanda Abbott is an author at Dana-Farber Cancer Institute specializing in clinical neuroscience, molecular pharmacology, and cognitive function.

Top concepts

Publications per year

1956–2021

7

Publications

7

Reduction of Brain Kynurenic Acid Improves Cognitive Function

Rouba Kozak, Brian Campbell, Christine A. Strick et al. · Journal of Neuroscience · 2014 · 172 citations · Full text

, , +20

NANETS/SNMMI Procedure Standard for Somatostatin Receptor–Based Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE

Thomas A. Hope, Amanda Abbott, Karen Colucci et al. · Journal of Nuclear Medicine · 2019 · 159 citations · Full text

Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study

Margaret von Mehren, Suzanne George, Michael C. Heinrich et al. · Clinical Cancer Research · 2019 · 64 citations · Full text

Guidance on <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division

Amanda Abbott, Christopher G. Sakellis, Eric Andersen et al. · Journal of Nuclear Medicine Technology · 2018 · 28 citations · Full text

Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation

Rouba Kozak, Tamás Kiss, Keith Dlugolenski et al. · Frontiers in Pharmacology · 2020 · 24 citations · Full text

Rows per page

1–5 of 7